Healx raised $10m Series A funding led by Balderton Capital

– UK, Cambridge – Healx, the technology company developing breakthrough treatments for rare diseases, today announced a $10 million Series A funding round led by Balderton Capital, Europe’s leading early-stage venture investor.…